|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tempero MA, Arnoletti JP, Behrman SW,
Ben-Josef E, Benson AB III, Casper ES, Cohen SJ, Czito B, Ellenhorn
JD, Hawkins WG, et al National Comprehensive Cancer Networks:
Pancreatic Adenocarcinoma, version 2.2012: Featured updates to the
NCCN Guidelines. J Natl Compr Canc Netw. 10:703–713.
2012.PubMed/NCBI
|
|
3
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burki TK: Whole-genome analysis of
pancreatic cancer. Lancet Oncol. 16:e1612015.
|
|
5
|
Levine AJ, Finlay CA and Hinds PW: P53 is
a tumor suppressor gene. Cell. 116:S67–S69, 61 p following S69.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whibley C, Pharoah PD and Hollstein M: p53
polymorphisms: Cancer implications. Nat Rev Cancer. 9:95–107. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Petitjean A, Achatz MI, Borresen-Dale AL,
Hainaut P and Olivier M: TP53 mutations in human cancers:
Functional selection and impact on cancer prognosis and outcomes.
Oncogene. 26:2157–2165. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomasini R, Samir AA, Vaccaro MI, Pebusque
MJ, Dagorn JC, Iovanna JL and Dusetti NJ: Molecular and functional
characterization of the stress-induced protein (SIP) gene and its
two transcripts generated by alternative splicing. SIP induced by
stress and promotes cell death. J Biol Chem. 276:44185–44192. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
N'guessan P, Pouyet L, Gosset G, Hamlaoui
S, Seillier M, Cano CE, Seux M, Stocker P, Culcasi M, Iovanna JL,
et al: Absence of tumor suppressor tumor protein 53-induced nuclear
protein 1 (TP53INP1) sensitizes mouse thymocytes and embryonic
fibroblasts to redox-driven apoptosis. Antioxid Redox Signal.
15:1639–1653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cano CE, Gommeaux J, Pietri S, Culcasi M,
Garcia S, Seux M, Barelier S, Vasseur S, Spoto RP, Pébusque MJ, et
al: Tumor protein 53-induced nuclear protein 1 is a major mediator
of p53 antioxidant function. Cancer Res. 69:219–226. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gommeaux J, Cano C, Garcia S, Gironella M,
Pietri S, Culcasi M, Pébusque MJ, Malissen B, Dusetti N, Iovanna J,
et al: Colitis and colitis-associated cancer are exacerbated in
mice deficient for tumor protein 53-induced nuclear protein 1. Mol
Cell Biol. 27:2215–2228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morimura R, Komatsu S, Ichikawa D,
Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H,
Okamoto K, et al: Novel diagnostic value of circulating miR-18a in
plasma of patients with pancreatic cancer. Br J Cancer.
105:1733–1740. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yan HL, Xue G, Mei Q, Wang YZ, Ding FX,
Liu MF, Lu MH, Tang Y, Yu HY and Sun SH: Repression of the
miR-17-92 cluster by p53 has an important function in
hypoxia-induced apoptosis. EMBO J. 28:2719–2732. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P,
Nie Y, Wu K, Shi Y and Fan D: MiR-19a/b modulate the metastasis of
gastric cancer cells by targeting the tumour suppressor MXD1. Cell
Death Dis. 5:e11442014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Naccarati A, Pardini B, Polakova V,
Smerhovsky Z, Vodickova L, Soucek P, Vrana D, Holcatova I, Ryska M
and Vodicka P: Genotype and haplotype analysis of TP53 gene and the
risk of pancreatic cancer: An association study in the Czech
Republic. Carcinogenesis. 31:666–670. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krüger J and Rehmsmeier M: RNAhybrid:
microRNA target prediction easy, fast and flexible. Nucleic Acids
Res. 34(Web Server): W451–W454. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kurokawa K, Tanahashi T, Iima T, Yamamoto
Y, Akaike Y, Nishida K, Masuda K, Kuwano Y, Murakami Y, Fukushima
M, et al: Role of miR-19b and its target mRNAs in 5-fluorouracil
resistance in colon cancer cells. J Gastroenterol. 47:883–895.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Xiao Z, Lai D, Sun J, He C, Chu
Z, Ye H, Chen S and Wang J: miR-21, miR-17 and miR-19a induced by
phosphatase of regenerating liver-3 promote the proliferation and
metastasis of colon cancer. Br J Cancer. 107:352–359. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harris CC and Hollstein M: Clinical
implications of the p53 tumor-suppressor gene. N Engl J Med.
329:1318–1327. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Green DR and Kroemer G: Cytoplasmic
functions of the tumour suppressor p53. Nature. 458:1127–1130.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Venkatanarayan A, Raulji P, Norton W,
Chakravarti D, Coarfa C, Su X, Sandur SK, Ramirez MS, Lee J,
Kingsley CV, et al: IAPP-driven metabolic reprogramming induces
regression of p53-deficient tumours in vivo. Nature. 517:626–630.
2015. View Article : Google Scholar :
|
|
24
|
Seillier M, Peuget S, Gayet O, Gauthier C,
N'Guessan P, Monte M, Carrier A, Iovanna JL and Dusetti NJ:
TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family
proteins through the LC3-interacting region (LIR) and promotes
autophagy-dependent cell death. Cell Death Differ. 19:1525–1535.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peuget S, Bonacci T, Soubeyran P, Iovanna
J and Dusetti NJ: Oxidative stress-induced p53 activity is enhanced
by a redox-sensitive TP53INP1 SUMOylation. Cell Death Differ.
21:1107–1118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tomasini R, Seux M, Nowak J, Bontemps C,
Carrier A, Dagorn JC, Pébusque MJ, Iovanna JL and Dusetti NJ:
TP53INP1 is a novel p73 target gene that induces cell cycle arrest
and cell death by modulating p73 transcriptional activity.
Oncogene. 24:8093–8104. 2005.PubMed/NCBI
|
|
27
|
Okamura S, Arakawa H, Tanaka T, Nakanishi
H, Ng CC, Taya Y, Monden M and Nakamura Y: p53DINP1, a
p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell.
8:85–94. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tomasini R, Samir AA, Pebusque MJ, Calvo
EL, Totaro S, Dagorn JC, Dusetti NJ and Iovanna JL: P53-dependent
expression of the stress-induced protein (SIP). Eur J Cell Biol.
81:294–301. 2002. View Article : Google Scholar : PubMed/NCBI
|
